| Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability JJL Williams, N Alotaiq, W Mullen, R Burchmore, L Liu, GS Baillie, ... Nature communications 9 (1), 168, 2018 | 32 | 2018 |
| Leveraging Therapeutic Proteins and Peptides from Lumbricus Earthworms: Targeting SOCS2 E3 Ligase for Cardiovascular Therapy through Molecular Dynamics … N Alotaiq, D Dermawan, NE Elwali International Journal of Molecular Sciences 25 (19), 10818, 2024 | 5 | 2024 |
| Therapeutic potential of earthworm-derived proteins: Targeting NEDD4 for cardiovascular disease intervention D Dermawan, F Alsenani, NE Elwali, N Alotaiq Journal of Applied Pharmaceutical Science 15 (1), 216-232, 2024 | 3 | 2024 |
| Evaluation of Structure Prediction and Molecular Docking Tools for Therapeutic Peptides in Clinical Use and Trials Targeting Coronary Artery Disease N Alotaiq, D Dermawan International Journal of Molecular Sciences 26 (2), 462, 2025 | 1 | 2025 |
| Advancements in Virtual Bioequivalence: A Systematic Review of Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry N Alotaiq, D Dermawan Pharmaceutics 16 (11), 1414, 2024 | 1 | 2024 |
| Targeting Cardiovascular Disease Receptors with Antimicrobial Peptides (AMPs): Molecular Docking and Dynamics Insights D Dermawan, N Alotaiq Preprints, 2024 | 1 | 2024 |
| Unveiling Pharmacological Mechanisms of Bombyx mori (Abresham), a Traditional Arabic Unani Medicine for Ischemic Heart Disease: An Integrative Molecular … D Dermawan, N Alotaiq Pharmaceutics 17 (3), 295, 2025 | | 2025 |
| Understanding the role of green tea and matcha consumption in cardiovascular health, obesity, and diabetes: Insights from a Saudi Arabian population F Alsenani, N Alotaiq, D Dermawan, MZ Nasrullah, RH Almalki, NT Alfarsi, ... Human Nutrition & Metabolism, 200302, 2025 | | 2025 |
| Targeting GSK‐3β for adipose dysfunction and cardiovascular complications of metabolic disease: An entangled WNT/β‐catenin question N Alotaiq, AS Khalifa, A Youssef, EG El‐Nagar, NE Elwali, HM Habib, ... The FASEB Journal 38 (24), e70273, 2024 | | 2024 |
| Computational analysis of antimicrobial peptides targeting key receptors in infection-related cardiovascular diseases: Molecular docking and dynamics insights D Dermawan, N Alotaiq | | 2024 |
| Advancements in Virtual Bioequivalence: Computational Methods and Regulatory Perspectives in the Pharmaceutical Industry N Alotaiq, D Dermawan | | 2024 |
| Leveraging Bioactive Proteins and Peptides from Lumbricus Earthworms: Targeting SOCS2 E3 Ligase for Cardiovascular Therapy through Molecular Dynamics Simulations N Alotaiq, D Dermawan | | 2024 |
| SUPPRESSOR OF CYTOKINE SIGNALLING 3 (SOCS3) INTERACTION WITH CAVIN-1 LINKS SOCS3 FUNCTION AND CAVIN-1 STABILITY JJL Williams, N Alotaiq, W Mullen, R Burchmore, L Liu, GS Baillie, ... BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 121, 73-73, 2017 | | 2017 |
| 212 Suppressor of cytokine signalling 3 (socs3) interaction with cavin-1 links socs3 function and cavin-1 stability J Williams, N Alotaiq, T Palmer Heart 103 (Suppl 5), A140-A140, 2017 | | 2017 |
| ROLES FOR A NOVEL CAVIN-1/SOCS3 INTERACTION IN REGULATING PRO-INFLAMMATORY IL-6 SIGNALLING AND CAVEOLA STABILITY NA Alotaiq, JJL Williams, TM Palmer Heart 100, A6, 2014 | | 2014 |
| Interaction of suppressor of cytokine signalling 3 with cavin | | |
| Human Nutrition & Metabolism F Alsenani, N Alotaiq, D Dermawan, MZ Nasrullah, RH Almalki, NT Alfarsi, ... | | |
Doni DermawanWarsaw University of TechnologyPreverjeni e-poštni naslov na pw.edu.pl